Variant Private Wealth’s Mustang Bio MBIO Stock Holding History

Variant Private Wealth’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-260	Closed	-$2.3K	–	41
2024 Q4	$2.3K	Buy	+260	New	+$2.87K	﹤0.01%	41

Other funds holding MBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Variant Private Wealth's MBIO Position: Q1 2025 in Review

Variant Private Wealth sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 260 shares — an estimated $2.3K sold.

Variant Private Wealth first reported a position in MBIO in Q4 2024 and held it in 1 quarter. The position peaked at $2.3K in Q4 2024. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

Variant Private Wealth reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
Variant Private Wealth sold 260 Mustang Bio shares in Q1 2025, an estimated $2.3K.
Variant Private Wealth first reported a position in Mustang Bio in Q4 2024 and held it in 1 quarter.
Variant Private Wealth's Mustang Bio position peaked at $2.3K in Q4 2024.
16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on Variant Private Wealth's 13F filing for Q1 2025, filed 17 Apr 2025.